Worldwide Industry for CAR-T Cell Therapy (2021 to 2027) - Players Profiled Include Aleta BioTherapeutics, Anixa Biosciences and BioNTech Among Others
Share this article Share this article ResearchAndMarkets.coms offering. CAR-T cell therapy is a remarkably promising treatment for cancer patients. It is a type of immunotherapy where doctors collect immune cells, modify them in a laboratory, and provide them the power to easily recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as "living drugs." T-cells form the backbone of CAR-T cell therapy. T-cells are the workhorses of our immune s...
Astellas Adaptimmune Allogene Maxcyte Juno Oxford Biomedica Kymriah Tisagenlecleucel Attars Biotherapeutics Cellectis Servier
Source: prnewswire.com